“…It is defined as an algorithm-based large-scale quantitative analysis of imaging features [ 12 , 13 , 14 , 15 ]. Such imaging biomarkers were shown to predict survival, tumor progression, spatial infiltration, and molecular aberrations in a multitude of cancer types [ 16 , 17 , 18 , 19 , 20 , 21 ]. In a recent publication, Spraker et al did demonstrate a prognostic potential of contrast-enhanced and fat-saturated T1-weighted (T1FSGd) sequence-based radiomics in STS patients [ 22 ].…”